Epsilon M&A Deal Report - Renal Services (UK)

Transaction Multiples for the Valuation of Private Companies

DaVita UK > Renal Services (UK)

Announced Date : 04 January 2021

Type : Exit ,Acquisition of Majority Stake

Deal Value : Yes

Acquirer : DaVita UK

Target: Renal Services (UK)

Target Country: United Kingdom

Sector of activity : Health, Pharmaceuticals & Biotechnology

Business Description :

> Founded in 2006 by Stefano Ciampolini, Renal Services (UK) is a healthcare provider specializin ...

No EMAT : 123556

Transaction multiples available

	EV/Sales	EV/Gross Profit	EV/EBITDA	EV/EBIT	Eq/PBT	P/E	Price to Book
Historic
Current

: Multiple available

n.s : Multiple calculated, but not significant

Rating ***

Source: Epsilon Research / EMAT

Comparable Transactions

Number of EMAT Reports : (Health, Pharmaceuticals & Biotechnology) = 1245

Example of comparable transactions on EMAT (same sub-sector):

Date	Acquirer	Target	Country	Multiples	See details
19/01/2022	Private Group backed by Lloyds Development Capital	EMS Group Solutions (EMS)	United Kingdom	**
11/04/2023	M42	Diaverum	Sweden	**

Source: Epsilon Research / EMAT

View Report

This report is accessible on EMAT, the reference database for private company acquisition multiples

Example of EMAT Report : click here

View Complete Report

About Epsilon Research

Epsilon Research is an independent research and financial analysis bureau, and the reference source of transaction multiples for the valuation of private companies through its EMAT database.

Sectors covered by our analysts

Studies & indices published by Epsilon Research Register to receive (free) publications updates

EMAT Report

Each EMAT Report includes the detailed analysis of the transaction: deal rationale and structure, target business lines and financials (restated), valuation multiples (calculation and analysis).

Subscribe to EMAT database